Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.

by Kateřina Kuželová, Barbora Brodská, Ota Fuchs, Marie Dobrovolná, Petr Soukup, Petr Cetkovský
Published 2015-01-01

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant <i>NPM1</i> and <i>FLT3</i> Mutations

by Barbora Brodská, Petra Otevřelová, Cyril Šálek, Ota Fuchs, Zdenka Gašová, Kateřina Kuželová
Published 2019-06-01

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

by Kateřina Kuželová, Barbora Brodská, Johannes Schetelig, Christoph Röllig, Zdeněk Ráčil, Juliane Stickel Walz, Grzegorz Helbig, Ota Fuchs, Milena Vraná, Pavla Pecherková, Cyril Šálek, Jiří Mayer
Published 2018-01-01

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes

by Miroslav Pribyl, Sona Hubackova, Alena Moudra, Marketa Vancurova, Helena Polackova, Tomas Stopka, Anna Jonasova, Radka Bokorova, Ota Fuchs, Jan Stritesky, Barbora Salovska, Jiri Bartek, Zdenek Hodny
Published 2020-10-01